Leebeek FWG - Search Results

1

The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?

Schütte LM, Hodes LS, van Moort I, Stoof SCM, Leebeek FWG, Cnossen MH, de Maat MPM, Kruip MJHA. Schütte LM, et al. Among authors: leebeek fwg. Haemophilia. 2020 Sep;26(5):916-922. doi: 10.1111/hae.14106. Epub 2020 Jul 26. Haemophilia. 2020. PMID: 32713129 Free PMC article.

2

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

3

Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.

van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MH, Kruip MJ, Kwakkel-van Erp JM, Leebeek FW, Nijkeuter M, Prins MH, Sohne M, Tick LW; Christopher Study Investigators. van Belle A, et al. JAMA. 2006 Jan 11;295(2):172-9. doi: 10.1001/jama.295.2.172. JAMA. 2006. PMID: 16403929

4

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Lisman T, et al. Hepatology. 2006 Jul;44(1):53-61. doi: 10.1002/hep.21231. Hepatology. 2006. PMID: 16799972

5

High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, Dippel DW, Leebeek FW. Bongers TN, et al. Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990571

6

Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.

de Bruijne EL, Darwish Murad S, de Maat MP, Tanck MW, Haagsma EB, van Hoek B, Rosendaal FR, Janssen HL, Leebeek FW; Liver and Thrombosis Study Group. de Bruijne EL, et al. Thromb Haemost. 2007 Feb;97(2):181-5. Thromb Haemost. 2007. PMID: 17264944

7

Evaluation of the AutoDimer D-dimer assay for the exclusion of pulmonary embolism.

Kruip MJ, van Vliet HH, Pattynama PM, Kars A, van den Meiracker AH, Jie KS, Leebeek FW. Kruip MJ, et al. Thromb Haemost. 2007 Feb;97(2):325-6. Thromb Haemost. 2007. PMID: 17264968 No abstract available.

8

The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.

Nijkeuter M, Söhne M, Tick LW, Kamphuisen PW, Kramer MH, Laterveer L, van Houten AA, Kruip MJ, Leebeek FW, Büller HR, Huisman MV; Christopher Study Investigators. Nijkeuter M, et al. Chest. 2007 Feb;131(2):517-23. doi: 10.1378/chest.05-2799. Chest. 2007. PMID: 17296656

9

Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge.

Nijkeuter M, Kwakkel-van Erp H, Söhne M, Tick LW, Kruip MJ, Ullmann EF, Kramer MH, Büller HR, Prins MH, Leebeek FW, Huisman MV; Christopher Study Investigators. Nijkeuter M, et al. Thromb Haemost. 2007 Jun;97(6):944-8. Thromb Haemost. 2007. PMID: 17549296

10

Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders.

Auwerda JJ, Sonneveld P, de Maat MP, Leebeek FW. Auwerda JJ, et al. Clin Lymphoma Myeloma. 2007 Jul;7(7):462-6. doi: 10.3816/clm.2007.n.027. Clin Lymphoma Myeloma. 2007. PMID: 17875234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters